Breast Cancer

Young black women have a higher prevalence of BRCA mutations compared with that previously reported among non-Hispanic white women, placing these women at a higher risk for breast and ovarian cancer.

Listening to music before undergoing ambulatory surgery for the diagnosis or treatment of breast cancer lessens patients' anxiety levels.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Researchers at Oregon Health & Science University found that breast cancer survivors who experience pain during sexual intercourse may achieve comfort when liquid lidocaine is applied strategically to prevent pain.

Anees B. Chagpar, MD, MSc, MA, MPH, discusses the role of the nurse in a contralateral prophylactic mastectomy.

Jessica Ryan, MD, breast surgeon, Elliot Breast Health Center, Manchester, New Hampshire, discusses the role of oncology nurses in extreme oncoplasty.

Guidelines for metastatic breast cancer developed.

A diagnosis of breast cancer is difficult at any age but for younger women, treatment decisions can be especially difficult, with implications that include their future childbearing, sexual health, and body image.

Sara M. Tolaney, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, discusses neoadjuvant treatment considerations for patients with triple-negative breast cancer (TNBC).

A new study has uncovered notable disparities in uptake of adjuvant breast cancer therapies in the Appalachian region of the United States, suggesting targeted intervention strategies may help to improve outcomes for this population of women.

Sunil Verma, MD, MSEd, FRCPC, discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer.

Breast cancer survivors are more likely to experience weight gain than cancer-free women of the same age and menopausal status, according to a recent study published in Cancer Epidemiology, Biomarkers & Prevention.

Sue Friedman, Executive Director, FORCE (Facing Our Risk of Cancer Empowered), discusses the importance of informed decision-making.

Melanie A. Nix, co-founder of the Breast Cancer Comfort Site, provides advices for a new cancer advocate.

Sue Friedman, discusses the ABOUT Network, which is the first-ever patient-powered research registry created and governed by and for people affected by hereditary breast and ovarian cancers.

If you meet a patient who is pregnant with a breast cancer diagnosis, a nurse navigator is invaluable, and there are many important considerations.

Mary B. Daly, MD, PhD, from Fox Chase Cancer Center, discusses the proper timing for screening patients with a family history of cancer.

Kara Maxwell, MD, PhD, instructor, medical oncologist, Basser Research Center for BRCA, University of Pennsylvania, discusses the need to personalize the treatment of breast cancer.

A study looking at the care experiences and possible stressors for Latina women undergoing chemotherapy to treat their breast cancer has found that this patient population feels particular stress related to their family and other interpersonal relationships.

The number of women deciding to have breast-conserving therapy to treat their early-stage breast cancer has been steadily increasing, but these gains are muted for some women due to such factors as insurance status, income, and travel distance to treatment centers.

Adding palbociclib (Ibrance) to standard fulvestrant more than doubled progression-free survival in pretreated patients with HR-positive, HER2-negative breast cancer, according to study results presented at the 2015 ASCO Annual Meeting.

Weight training was shown to help stave off deterioration of physical function in breast cancer survivors, conferring a benefit twice that of women in a control group who did not participate in the weight-lifting intervention.

Imagine a woman with a weight problem who, two weeks after chemotherapy, goes to her doctor with a urinary tract infection and a rash on her upper chest.

Breast density, which is associated with breast cancer risk, is higher in black/African-American women than in white women, according to research presented at the AACR Annual Meeting.

The PD-L1 inhibitor MPDL3280A demonstrated a 19% objective response rate (ORR) with 75% of responses ongoing in pretreated patients with metastatic triple-negative breast cancer (TNBC), according to findings from an ongoing phase I study presented at the 2015 AACR Annual Meeting.

New research reported at the AACR Annual Meeting has found that decreasing the number of hours spent eating each day and increasing the number of hours spent fasting overnight may reduce a woman's risk of developing breast cancer.

A new telephone-based intervention for breast cancer survivors is showing promise, and it involves them becoming more actively engaged in goal setting and problem solving with an eye toward accelerating their recovery by engaging in health-promoting activities such as exercise, stress management, and healthy eating.

Many women who are diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer. However, a large amount of those concerns are not being addressed, according to a new study.

Angelina Jolie Pitt recently added another chapter to her BRCA mutation story, making public her choice to undergo a preventive salpingo-oophorectomy, removal of her ovaries and fallopian tubes to reduce her risk of cancer.

The link between diabetes and late-stage breast cancer is strong, according to a new study.